Private treatment centers are important in delivering drug abuse treatment services. As privately-funded centers competing for scarce resources, their response to new treatment technologies should be especially dynamic. We would address the adoption of new treatment practices through cross-sectional and longitudinal data within an existing representative national sample of 450 private for-profit and not-for-profit substance abuse treatment centers, with two phases of data collection: 1. Following instrumentation, we would conduct on-site visits at the 450 centers. This new data collection would focus upon an updating of the organizational and managerial features of the treatment centers, would involve collection of new data germane to new practice adoption. This would generate a generalizable description of the patterns of new practice adoption across this sample of treatment centers and would allow for testing hypotheses about organizational and managerial correlates of patterns of adoption. 2. The second phase would involve a re- visit to the sample of centers, with an updating of organizational and managerial data, and a reassessment of data about new treatment practice adoption. With the phase 1 baselines, we could describe the process dynamics of new practice adoption and move toward the construction of causal models of program adoption. Classes of independent variables that may be linked to different patterns of adoption behavior are: (1) the external environment surrounding the treatment organization, (2) the treatment center's internal organizational and managerial environment, and (3) the treatment center's organizational culture. In terms of """"""""outcome"""""""" behaviors, every treatment center would fall in one of 7 empirical categories relative to the center's response to a new substance abuse treatment practice. In specifying the innovations and outcome measurements, we propose to work with an Expert Panel in deriving a set of treatment practice innovations for study within two general realms: new medications and new psychosocial treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA013110-04
Application #
6523107
Study Section
Special Emphasis Panel (ZDA1-KXN-G (08))
Program Officer
Hilton, Thomas
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$624,914
Indirect Cost
Name
University of Georgia
Department
Psychology
Type
Other Domestic Higher Education
DUNS #
City
Athens
State
GA
Country
United States
Zip Code
30602
Fields, Dail; Knudsen, Hannah K; Roman, Paul M (2016) Implementation of Network for the Improvement of Addiction Treatment (NIATx) Processes in Substance Use Disorder Treatment Centers. J Behav Health Serv Res 43:354-65
Fields, Dail; Riesenmy, Kelly; Blum, Terry C et al. (2015) Implementation of Electronic Health Records and Entrepreneurial Strategic Orientation in Substance Use Disorder Treatment Organizations. J Stud Alcohol Drugs 76:942-51
Edmond, Mary Bond; Aletraris, Lydia; Roman, Paul M (2015) Rural substance use treatment centers in the United States: an assessment of treatment quality by location. Am J Drug Alcohol Abuse :1-9
Blum, Terry C; Davis, Carolyn D; Roman, Paul M (2014) Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams. J Health Hum Serv Adm 37:37-75
Rieckmann, Traci R; Abraham, Amanda J; Kovas, Anne E et al. (2014) Impact of research network participation on the adoption of buprenorphine for substance abuse treatment. Addict Behav 39:889-96
Abraham, Amanda J; O'Brien, Lauren A; Knudsen, Hannah K et al. (2013) Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat 44:120-5
Bride, Brian E; Abraham, Amanda J; Kintzle, Sara et al. (2013) Social workers' knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders. Soc Work Health Care 52:43-58
Abraham, Amanda J; Knudsen, Hannah K; Rieckmann, Traci et al. (2013) Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States. J Stud Alcohol Drugs 74:258-65
Knudsen, Hannah K; Muilenburg, Jessica; Eby, Lillian T (2013) Sustainment of smoking cessation programs in substance use disorder treatment organizations. Nicotine Tob Res 15:1060-8
Savage, Sarah A; Abraham, Amanda J; Knudsen, Hannah K et al. (2012) Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages. J Subst Abuse Treat 42:16-24

Showing the most recent 10 out of 64 publications